If you wish to become a partner for this event and for our coming conferences, please contact Organizing Committee to learn more about potential partner inputs Maria Isanguliants maria.isangouliantis@rsu.lv

Partners


International Society for Vaccines (ISV) is an organization that engages, supports, and sustains the professional goals of a diverse membership in all areas relevant to vaccines.

Active members of ISV including ISV Board, such as Prof Shan Lu, Prof Margaret Liu, Prof Anna-Lise Williamson, Prof Joon H Rhee, Prof Ed Rubycki, Prof Roger LeGrand support TECHAVAC2020 acting as key lecturers in five main sessions.

To find more, please, click the link https://isv-online.org/


Peoples’ Friendship university of Russia (PFUR) is one of the leading higher educational institutions of Russia. It is the only university in the world that annually unites students from about 150 countries. PFUR consists of 6 faculties including engineering, natural, medical, economic, humanitarian, 10 institutes and 1 academy. Novel structure within PFUR created within the framework of the Strategic and Academic Leadership Program is the Translation Medicine Cluster that acts as the co-organizer and supporter of the symposium. 

To find more, please, click the link https://eng.rudn.ru

Rīga Stradiņš University (RSU) is an advanced institution of higher medical education in Latvia and also one of the leading in Europe. RSU offers several levels of education, up-to Master lines, with 6500 students and 400 academic staff. RSU has regularly 4500 undergraduate and professional program students covering all medical professions, around 200 PhD students, and is the largest entity in the Baltic States in the area of medicine and health sciences and training. RSU has long-standing and rich experience in medical and healthcare research, including infectology, epidemiology, virology and oncology and comprehensive infrastructure for virus and cancer research.

To find more, please, click the link www.rsu.lv

The National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, founded in 1891, is one of the world’s leading research institutes in its area. The Center carries fundamental and applied research in epidemiology, medical microbiology, genetics and molecular biology of bacteria and viruses, immunology of infections, cell microbiology and bioengineering. It has a unique collection of viruses, and has its own vaccine production line. It has successfully engineered and registered two vaccines for the Ebola fever using adenovirus vectors, and was the first on the market to register COVID-19 vaccine “Sputnik-V” designed using the same platform.

To find more, please, click the link, https://gamaleya.org/

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.

The journal welcomes submissions in the pathogen-related cancer areas and other related topics pertinent to the development of therapies for chronic infections and cancer.

Of particular interest are HPV and anogenital cancers (as well as head and neck cancers), EBV and Burkitt lymphoma, HCV/HBV and hepatocellular carcinoma (as well as lymphoproliferative diseases), HHV8 and Kaposi sarcoma, HTLV and leukemia and Cancers in Low- and Middle-income countries.

To find more, please, click the link, https://infectagentscancer.biomedcentral.com/


Download (PDF, 127KB)

START TYPING AND PRESS ENTER TO SEARCH